↓ Skip to main content

Development of New Formulations of Biologics: Expectations, Immunogenicity, and Safety for Subcutaneous Trastuzumab

Overview of attention for article published in Pharmaceutical Medicine, September 2018
Altmetric Badge

About this Attention Score

  • Among the highest-scoring outputs from this source (#44 of 151)
  • Above-average Attention Score compared to outputs of the same age (64th percentile)

Mentioned by

twitter
1 X user
patent
2 patents

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
56 Mendeley
Title
Development of New Formulations of Biologics: Expectations, Immunogenicity, and Safety for Subcutaneous Trastuzumab
Published in
Pharmaceutical Medicine, September 2018
DOI 10.1007/s40290-018-0247-5
Pubmed ID
Authors

Franklin Fernandes Pimentel, Gilberto Morgan, Daniel Guimarães Tiezzi, Jurandyr Moreira de Andrade

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 56 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 16%
Student > Bachelor 7 13%
Student > Master 6 11%
Student > Ph. D. Student 5 9%
Student > Postgraduate 4 7%
Other 10 18%
Unknown 15 27%
Readers by discipline Count As %
Medicine and Dentistry 17 30%
Pharmacology, Toxicology and Pharmaceutical Science 12 21%
Nursing and Health Professions 3 5%
Agricultural and Biological Sciences 2 4%
Economics, Econometrics and Finance 2 4%
Other 2 4%
Unknown 18 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 May 2023.
All research outputs
#6,840,094
of 23,105,443 outputs
Outputs from Pharmaceutical Medicine
#44
of 151 outputs
Outputs of similar age
#120,167
of 340,834 outputs
Outputs of similar age from Pharmaceutical Medicine
#3
of 4 outputs
Altmetric has tracked 23,105,443 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 151 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 340,834 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one.